{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:14:08Z","timestamp":1792030448275,"version":"4.4.0"},"reference-count":56,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Rosacea is a common chronic disease of the facial region characterized by erythema, flushing, papules, pustules, phymatous changes and ocular symptoms. Despite its prevalence, the inflammatory pathways underlying rosacea remain poorly understood, and reliable biomarkers for assessing disease severity have not been established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate whether specific immune biomarkers are elevated in lesional rosacea skin compared with skin-healthy controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we employed a noninvasive skin tape-stripping technique to evaluate levels of certain cutaneous biomarkers in patients with rosacea compared with individuals with healthy skin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Levels of the following biomarkers were increased in patients with rosacea compared with individuals with healthy skin: interleukin (IL)-1RA, IL-8, IL-12p70, IL-17A, IL-17E, IL-17F, IL-18, IL-22, interferon (IFN)-\u03b3, inducible protein (IP)-10, IFN-\u03b3, vascular endothelial growth factor (VEGF)-\u03b1 and thymus and activation regulated chemokine (TARC). Increasing severity of rosacea (measured by the Rosacea Area and Severity Index) was positively correlated with higher concentrations of IFN-\u03b3, IL-18, IP-10, VEGF-\u03b1 and IL-17F.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our data suggest that dysregulation of both innate and adaptive immune responses, particularly involving T helper (Th) 1 and Th17 pathways, plays a critical role in rosacea pathogenesis and severity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ced\/llag281","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:46:30Z","timestamp":1783424790000},"source":"Crossref","is-referenced-by-count":1,"title":["Cutaneous inflammatory biomarkers in rosacea and their association with disease severity"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3243-0796","authenticated-orcid":false,"given":"Nita K F","family":"Wienholtz","sequence":"first","affiliation":[{"name":"Department of Neurology, Danish Headache Center, Copenhagen University Hospital \u2013 Rigshospitalet , Copenhagen ,","place":["Denmark"]},{"name":"Department of Dermatology, Bispebjerg and Frederiksberg, Copenhagen University , Copenhagen ,","place":["Denmark"]},{"name":"Department of Dermatology and Allergy, Copenhagen University Hospital \u2013 Herlev and Gentofte Hospitals , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8257-1816","authenticated-orcid":false,"given":"Alexander","family":"Egeberg","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Bispebjerg and Frederiksberg, Copenhagen University , Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, University of Copenhagen , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1063-4547","authenticated-orcid":false,"given":"Sanja","family":"Kezic","sequence":"additional","affiliation":[{"name":"Department of Public and Occupational Health, Amsterdam Public Health Research Institute, Amsterdam University Medical Center , Amsterdam ,","place":["the\u00a0Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ungar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Icahn School of Medicine at Mount Sinai , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Zachariae","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy, Copenhagen University Hospital \u2013 Herlev and Gentofte Hospitals , Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, University of Copenhagen , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Messoud","family":"Ashina","sequence":"additional","affiliation":[{"name":"Department of Neurology, Danish Headache Center, Copenhagen University Hospital \u2013 Rigshospitalet , Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, University of Copenhagen , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob P","family":"Thyssen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Bispebjerg and Frederiksberg, Copenhagen University , Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, University of Copenhagen , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"2026092404072645300_llag281-B1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jaad.2017.08.037","article-title":"Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee","volume":"78","author":"Gallo","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"2026092404072645300_llag281-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2022.1026447","article-title":"Clinical characteristics of combined rosacea and migraine","volume":"9","author":"Wienholtz","year":"2022","journal-title":"Front Med"},{"key":"2026092404072645300_llag281-B3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s40257-021-00595-7","article-title":"Rosacea: new concepts in classification and treatment","volume":"22","author":"van Zuuren","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"2026092404072645300_llag281-B4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/bjd.15122","article-title":"Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel","volume":"176","author":"Tan","year":"2017","journal-title":"Br J Dermatol"},{"key":"2026092404072645300_llag281-B5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/jidsymp.2011.9","article-title":"Rosacea: the cytokine and chemokine network","volume":"15","author":"Gerber","year":"2011","journal-title":"J Investig Dermatol"},{"key":"2026092404072645300_llag281-B6","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.12688\/f1000research.16537.1","article-title":"Recent advances in understanding and managing rosacea","volume":"7","author":"Buddenkotte","year":"2018","journal-title":"F1000Res"},{"key":"2026092404072645300_llag281-B7","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/jid.2015.141","article-title":"Molecular and morphological characterization of inflammatory infiltrate in rosacea reveals activation of Th1\/Th17 pathways","volume":"135","author":"Buhl","year":"2015","journal-title":"J Invest Dermatol"},{"key":"2026092404072645300_llag281-B8","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/exd.12030","article-title":"Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation","volume":"21","author":"Casas","year":"2012","journal-title":"Exp Dermatol"},{"key":"2026092404072645300_llag281-B9","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/jdv.19732","article-title":"Biomarkers in rosacea: a systematic review","volume":"38","author":"Geng","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026092404072645300_llag281-B10","article-title":"The multifaceted role of Th1, Th9, and Th17 cells in immune checkpoint inhibition therapy","volume":"12","author":"Lee","year":"2021","journal-title":"Front Immunol"},{"key":"2026092404072645300_llag281-B11","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151846","article-title":"Type I IFNs link skin-associated dysbiotic commensal bacteria to pathogenic inflammation and angiogenesis in rosacea","volume":"8","author":"Mylonas","year":"2023","journal-title":"JCI Insight"},{"key":"2026092404072645300_llag281-B12","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jid.2020.08.013","article-title":"Paired transcriptomic and proteomic analysis implicates IL-1\u03b2 in the pathogenesis of papulopustular rosacea explants","volume":"141","author":"Harden","year":"2021","journal-title":"J Invest Dermatol"},{"key":"2026092404072645300_llag281-B13","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/jocd.14169","article-title":"Serum IL-17 levels in patients with rosacea","volume":"21","author":"Hayran","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"2026092404072645300_llag281-B14","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/exd.12745","article-title":"Recombinant erythroid differentiation regulator 1 inhibits both inflammation and angiogenesis in a mouse model of rosacea","volume":"24","author":"Kim","year":"2015","journal-title":"Exp Dermatol"},{"key":"2026092404072645300_llag281-B15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109181","article-title":"Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea","volume":"117","author":"Yuan","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"2026092404072645300_llag281-B16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/1346-8138.16329","article-title":"Increased serum levels of CCL3, CXCL8, CXCL9, and CXCL10 in rosacea patients and their correlation with disease severity","volume":"49","author":"Liu","year":"2022","journal-title":"J Dermatol"},{"key":"2026092404072645300_llag281-B17","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jid.2021.01.004","article-title":"Research techniques made simple: stratum corneum tape stripping","volume":"141","author":"Keurentjes","year":"2021","journal-title":"J Invest Dermatol"},{"key":"2026092404072645300_llag281-B18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-039445","article-title":"Cohort profile\u202f: COpenhagen ROsacea COhort (COROCO) and COpenhagen MIgraine COhort (COMICO)","volume":"10","author":"Wienholtz","year":"2020","journal-title":"BMJ Open"},{"key":"2026092404072645300_llag281-B19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/jdv.18721","article-title":"Validity and reliability of the Rosacea Area and Severity Index (RASI): a scoring system for clinical assessment of rosacea severity","volume":"37","author":"Wienholtz","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026092404072645300_llag281-B20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1600-0846.2007.00242.x","article-title":"Cytokines at different stratum corneum levels in normal and sodium lauryl sulphate-irritated skin","volume":"13","author":"De Jongh","year":"2007","journal-title":"Ski Res Technol"},{"key":"2026092404072645300_llag281-B21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78943-6","article-title":"Cytokine concentration across the stratum corneum in atopic dermatitis and healthy controls","volume":"10","author":"Clausen","year":"2020","journal-title":"Sci Rep"},{"key":"2026092404072645300_llag281-B22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/1047322X.1990.10389587","article-title":"Estimation of average concentration in the presence of nondetectable values","volume":"5","author":"Hornung","year":"1990","journal-title":"Appl Occup Environ Hyg"},{"key":"2026092404072645300_llag281-B23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00281-018-0675-z","article-title":"Skin neurogenic inflammation","volume":"40","author":"Choi","year":"2018","journal-title":"Semin Immunopathol"},{"key":"2026092404072645300_llag281-B24","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"2026092404072645300_llag281-B25","first-page":"420","article-title":"Demodex mites modulate sebocyte immune reaction: possible role in the pathogenesis of rosacea","volume":"179","author":"Lacey","year":"2018","journal-title":"Br J Dermatol"},{"key":"2026092404072645300_llag281-B26","doi-asserted-by":"crossref","DOI":"10.5826\/dpc.1404a267","article-title":"Serum biomarkers IL-6 and HIF-1\u03b1 in rosacea: assessing their significance in disease pathogenesis and telangiectasia formation","volume":"14","author":"Tas Aygar","year":"2024","journal-title":"Dermatol Pract Concept"},{"key":"2026092404072645300_llag281-B27","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3390\/vaccines9111224","article-title":"The involvement of CXC motif chemokine ligand 10 (CXCL10) and its related chemokines in the pathogenesis of coronary artery disease and in the COVID-19 vaccination: a narrative review","volume":"9","author":"Karimabad","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"2026092404072645300_llag281-B28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1081\/CUS-120019326","article-title":"Application of a novel and noninvasive skin sampling technique for analyzing cytokine-mediated inflammation in rosacea","volume":"22","author":"Robinson","year":"2003","journal-title":"J Toxicol Cutan Ocul Toxicol"},{"key":"2026092404072645300_llag281-B29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cyto.2010.08.009","article-title":"Tear cytokines and chemokines in patients with Demodex blepharitis","volume":"53","author":"Kim","year":"2011","journal-title":"Cytokine"},{"key":"2026092404072645300_llag281-B30","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"2026092404072645300_llag281-B31","article-title":"Ivermectin: a multifaceted drug with a potential beyond anti-parasitic therapy","volume":"16","author":"Kaur","year":"2024","journal-title":"Cureus"},{"key":"2026092404072645300_llag281-B32","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/ajd.14377","article-title":"Interleukin-17 inhibitors for the management of severe rosacea","volume":"65","author":"Sarsam","year":"2024","journal-title":"Australas J Dermatol"},{"key":"2026092404072645300_llag281-B33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s40259-024-00687-w","article-title":"Interleukin-17 inhibitors in the treatment of hidradenitis suppurativa","volume":"39","author":"Pinto Salgueiro","year":"2025","journal-title":"BioDrugs"},{"key":"2026092404072645300_llag281-B34","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/1203475419867611","article-title":"The role of IL-17 in papulopustular rosacea and future directions","volume":"23","author":"Amir Ali","year":"2019","journal-title":"J Cutan Med Surg"},{"key":"2026092404072645300_llag281-B35","first-page":"371","article-title":"Concentration of selected cytokines in serum of patients with acne rosacea","volume":"65","author":"Salamon","year":"2008","journal-title":"Przegl Lek"},{"key":"2026092404072645300_llag281-B36","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/jlb.63.6.658","article-title":"Overview of interleukin-18: more than an interferon-gamma inducing factor","volume":"63","author":"Dinarello","year":"1998","journal-title":"J Leukoc Biol"},{"key":"2026092404072645300_llag281-B37","article-title":"Interleukin-18 and IL-18BP in inflammatory dermatological diseases","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"2026092404072645300_llag281-B38","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.4049\/jimmunol.167.3.1644","article-title":"Evidence of IL-18 as a novel angiogenic mediator","volume":"167","author":"Park","year":"2001","journal-title":"J Immunol"},{"key":"2026092404072645300_llag281-B39","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaci.2024.10.027","article-title":"IL-9 sensitizes human TH2 cells to proinflammatory IL-18 signals in atopic dermatitis","volume":"155","author":"Sch\u00e4rli","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"2026092404072645300_llag281-B40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1403798","article-title":"Therapeutic strategies focusing on immune dysregulation and neuroinflammation in rosacea","volume":"15","author":"Tu","year":"2024","journal-title":"Front Immunol"},{"key":"2026092404072645300_llag281-B41","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.3390\/ijms24055001","article-title":"Molecular mechanisms of neurogenic inflammation of the skin","volume":"24","author":"Marek-Jozefowicz","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026092404072645300_llag281-B42","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1177\/03331024221118924","article-title":"The role of cytokines in migraine: a systematic review","volume":"42","author":"Thuraiaiyah","year":"2022","journal-title":"Cephalalgia"},{"key":"2026092404072645300_llag281-B43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jocn.2022.02.026","article-title":"Aberrations in peripheral inflammatory cytokine levels in migraine: a systematic review and meta-analysis","volume":"98","author":"Geng","year":"2022","journal-title":"J Clin Neurosci"},{"key":"2026092404072645300_llag281-B44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s10194-023-01572-7","article-title":"Cytokines in primary headache disorders: a systematic review and meta-analysis","volume":"24","author":"Musubire","year":"2023","journal-title":"J Headache Pain"},{"key":"2026092404072645300_llag281-B45","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s10194-025-02136-7","article-title":"Distinct inflammatory profiles across migraine states: a systematic review and meta-analysis","volume":"26","author":"Stuchfield-Denby","year":"2025","journal-title":"J Headache Pain"},{"key":"2026092404072645300_llag281-B46","doi-asserted-by":"crossref","first-page":"8779","DOI":"10.1097\/MS9.0000000000004121","article-title":"Serum inflammatory cytokines as biomarkers for predicting chronic migraine transformation: a systematic review of randomized controlled trials","volume":"87","author":"Syed","year":"2025","journal-title":"Ann Med Surg"},{"key":"2026092404072645300_llag281-B47","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1159\/000514308","article-title":"Comparison of cytokines in skin biopsies and tape strips from adults with atopic dermatitis","volume":"237","author":"Simonsen","year":"2021","journal-title":"Dermatology"},{"key":"2026092404072645300_llag281-B48","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1046\/j.1526-4610.2001.01140.x","article-title":"Immunological aspects in migraine: increase of IL-10 plasma levels during attack","volume":"41","author":"Munno","year":"2001","journal-title":"Headache"},{"key":"2026092404072645300_llag281-B49","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s001090050130","article-title":"Inhibition of intercellular adhesion molecule-1 (ICAM-1), soluble ICAM-1 and interleukin-4 by nitric oxide expression in migraine patients","volume":"75","author":"Martelletti","year":"1997","journal-title":"J Mol Med"},{"key":"2026092404072645300_llag281-B50","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jneuroim.2005.10.005","article-title":"The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine","volume":"171","author":"Fidan","year":"2006","journal-title":"J Neuroimmunol"},{"key":"2026092404072645300_llag281-B51","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1526-4610.2004.04189.x","article-title":"Chemokine levels in the jugular venous blood of migraine without aura patients during attacks","volume":"44","author":"Sarchielli","year":"2004","journal-title":"Headache"},{"key":"2026092404072645300_llag281-B52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s10194-021-01377-6","article-title":"Assessment of peripheral biomarkers potentially involved in episodic and chronic migraine: a case\u2013control study with a focus on NGF, BDNF, VEGF, and PGE2","volume":"23","author":"Mozafarihashjin","year":"2022","journal-title":"J Headache Pain"},{"key":"2026092404072645300_llag281-B53","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/bjd.19703","article-title":"Topical corticosteroids normalize both skin and systemic inflammatory markers in infant atopic dermatitis","volume":"185","author":"McAleer","year":"2021","journal-title":"Br J Dermatol"},{"key":"2026092404072645300_llag281-B54","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jaad.2019.10.039","article-title":"The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature","volume":"82","author":"Pavel","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2026092404072645300_llag281-B55","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3389\/fimmu.2020.01768","article-title":"Tape-strip proteomic profiling of atopic dermatitis on dupilumab identifies minimally invasive biomarkers","volume":"11","author":"He","year":"2020","journal-title":"Front Immunol"},{"key":"2026092404072645300_llag281-B56","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaad.2014.05.036","article-title":"The psychological impact of rosacea and the influence of current management options","volume":"71","author":"Moustafa","year":"2014","journal-title":"J Am Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llag281\/68718229\/llag281.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llag281\/68718229\/llag281.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:07:38Z","timestamp":1790237258000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/advance-article\/doi\/10.1093\/ced\/llag281\/8728232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":56,"URL":"https:\/\/doi.org\/10.1093\/ced\/llag281","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"article-number":"llag281"}}